Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury

Michael Buerke1, Markus Guckenbiehl1, Hansjörg Schwertz1, Ute Buerke1, Michael Hilker2, Herbert Platsch3, Joachim Richert3, Sabine Bomm3, Guy A. Zimmerman4, Stephan Lindemann4, Ursula Mueller-Werdan1, Karl Werdan1, Harald Darius5, Andrew S. Weyrich4
1Department of Medicine III, Martin-Luther-University, Ernst-Grube-Str. 40, 06097 Halle, Germany
2Cardiothoracic and Vascular Surgery, Johannes Gutenberg-University, Mainz, Germany
3BASF AG, Ludwigshafen, Germany
4Eccles Institute of Human Genetics, Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, Utah, USA
5Department of Cardiology, Neu-Kölln-Hospital, Berlin, Germany

Tài liệu tham khảo

Fuster, 1995, The three processes leading to post PTCA restenosis: dependence on the lesion substrate, Thromb. Haemost., 74, 552, 10.1055/s-0038-1642737 Landau, 1994, Percutaneous transluminal coronary angioplasty, N. Engl. J. Med., 330, 981, 10.1056/NEJM199404073301407 Gibbons, 1994, The emerging concept of vascular remodeling, N. Engl. J. Med., 330, 1431, 10.1056/NEJM199405193302008 Li, 1998, Elastin is an essential determinant of arterial morphogenesis, Nature, 393, 276, 10.1038/30522 Tai, 2000, Determination of temporal expression patterns for multiple genes in the rat carotid artery injury model, Arterioscler. Thromb. Vasc. Biol., 20, 2184, 10.1161/01.ATV.20.10.2184 Raines, 2000, The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease, Int. J. Exp. Pathol., 81, 173, 10.1046/j.1365-2613.2000.00155.x Zohlnhofer, 2001, Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation, Circulation, 103, 1396, 10.1161/01.CIR.103.10.1396 Popov, 1975, Reliable micromethod for determination of the protein content in tissue homogenates, Acta Biol. Med. Ger., 34, 1441 Heukeshoven, 1988, Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels, Electrophoresis, 9, 28, 10.1002/elps.1150090106 Sousa, 2001, Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study, Circulation, 103, 192, 10.1161/01.CIR.103.2.192 Sousa, 2001, Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up, Circulation, 104, 2007, 10.1161/hc4201.098056 Rensing, 2001, Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up, Eur. Heart J., 22, 2125, 10.1053/euhj.2001.2892 Abraham, 1996, Immunopharmacology of rapamycin, Annu. Rev. Immunol., 14, 483, 10.1146/annurev.immunol.14.1.483 Gregory, 1993, Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels, Transplantation, 55, 1409, 10.1097/00007890-199306000-00037 Meiser, 1991, Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease, Lancet, 338, 1297, 10.1016/0140-6736(91)92594-R Guba, 2002, Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor, Nat. Med., 8, 128, 10.1038/nm0202-128 Morice, 1993, Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes, J. Biol. Chem., 268, 3734, 10.1016/S0021-9258(18)53755-8 Albers, 1993, An FKBP-rapamycin-sensitive, cyclin-dependent kinase activity that correlates with the FKBP-rapamycin-induced G1 arrest point in MG-63 cells, Ann. N. Y. Acad. Sci., 696, 54, 10.1111/j.1749-6632.1993.tb17142.x Gingras, 2001, Regulation of translation initiation by FRAP/mTOR, Genes Dev., 15, 807, 10.1101/gad.887201 Weyrich, 1998, Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets, Proc. Natl. Acad. Sci. U. S. A., 95, 5556, 10.1073/pnas.95.10.5556 Gallo, 1999, Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle, Circulation, 99, 2164, 10.1161/01.CIR.99.16.2164 Burke, 1999, Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin, J. Cardiovasc. Pharmacol., 33, 829, 10.1097/00005344-199906000-00001 Strauss, 1994, Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis, Circ. Res., 75, 650, 10.1161/01.RES.75.4.650 Ju, 1996, Extracellular matrix and cardiovascular diseases, Can. J. Cardiol., 12, 1259 Lafont, 1999, Endothelial dysfunction and collagen accumulation: two independent factors for restenosis and constrictive remodeling after experimental angioplasty, Circulation, 100, 1109, 10.1161/01.CIR.100.10.1109 Imanaka-Yoshida, 2001, Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-C expression, Virchows Arch., 439, 185, 10.1007/s004280000390 Pradet-Balade, 2001, Translation control: bridging the gap between genomics and proteomics?, Trends Biochem. Sci., 26, 225, 10.1016/S0968-0004(00)01776-X Lindemann, 2001, Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis, J. Cell Biol., 154, 485, 10.1083/jcb.200105058 Lindemann, 2001, Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control, J. Biol. Chem., 276, 33947, 10.1074/jbc.M104281200 Kraiss, 2000, Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells, Am. J. Physiol, Heart Circ. Physiol., 278, H1537, 10.1152/ajpheart.2000.278.5.H1537 Dixon, 2001, Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells, J. Clin. Invest., 108, 1657, 10.1172/JCI12973 Dyer, 1997, Cell cycle changes in A-type lamin associations detected in human dermal fibroblasts using monoclonal antibodies, Chromosome Res., 5, 383, 10.1023/A:1018496309156 Kocher, 1991, Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies, Lab. Invest., 65, 459 Worth, 2001, Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins, Cell Motil. Cytoskelet., 49, 130, 10.1002/cm.1027 Inoue, 1994, Serial changes of coronary arteries after percutaneous transluminal coronary angioplasty: histopathological and immunohistochemical study, J. Cardiol., 24, 279 Hawkins, 2000, Calcium signaling and annexins, Cell Biochem. Biophys., 33, 275, 10.1385/CBB:33:3:275 Babiychuk, 2000, Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains, J. Cell Biol., 150, 1113, 10.1083/jcb.150.5.1113 Dabbagh, 2001, Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways, J. Cell. Physiol., 186, 73, 10.1002/1097-4652(200101)186:1<73::AID-JCP1002>3.0.CO;2-Q Mounkes, 2001, The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases, Trends Cardiovasc. Med., 11, 280, 10.1016/S1050-1738(01)00126-8 Dichtl, 2000, The carboxyl-terminal fragment of alpha1-antitrypsin is present in atherosclerotic plaques and regulates inflammatory transcription factors in primary human monocytes, Mol. Cell Biol. Res. Commun., 4, 50, 10.1006/mcbr.2000.0256 Marx, 1995, Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells, Circ. Res., 76, 412, 10.1161/01.RES.76.3.412 Yost, 2004, Activated polymorphonuclear leucocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events, J. Exp. Med., 200, 671, 10.1084/jem.20040224